Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2018 1
2020 2
2021 6
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
CAR T cells: Building on the CD19 paradigm.
Globerson Levin A, Rivière I, Eshhar Z, Sadelain M. Globerson Levin A, et al. Eur J Immunol. 2021 Sep;51(9):2151-2163. doi: 10.1002/eji.202049064. Epub 2021 Aug 2. Eur J Immunol. 2021. PMID: 34196410 Free PMC article. Review.
T Cells Retain Pivotal Antitumoral Functions under Tumor-Treating Electric Fields.
Diamant G, Simchony Goldman H, Gasri Plotnitsky L, Roitman M, Shiloach T, Globerson-Levin A, Eshhar Z, Haim O, Pencovich N, Grossman R, Ram Z, Volovitz I. Diamant G, et al. Among authors: globerson levin a. J Immunol. 2021 Jul 15;207(2):709-719. doi: 10.4049/jimmunol.2100100. Epub 2021 Jul 2. J Immunol. 2021. PMID: 34215656
Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer.
Deshet-Unger N, Horn G, Rawet-Slobodkin M, Waks T, Laskov I, Michaan N, Raz Y, Bar V, Zundelevich A, Aharon S, Turovsky L, Mallel G, Salpeter S, Neev G, Hollander KS, Katz BZ, Grisaru D, Globerson Levin A. Deshet-Unger N, et al. Among authors: globerson levin a. Biomedicines. 2022 Sep 7;10(9):2216. doi: 10.3390/biomedicines10092216. Biomedicines. 2022. PMID: 36140319 Free PMC article.
Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL Cells.
Shorer Arbel Y, Katz BZ, Gabizon R, Shraga A, Bronstein Y, Kamdjou T, Globerson Levin A, Perry C, Avivi I, London N, Herishanu Y. Shorer Arbel Y, et al. Among authors: globerson levin a. Front Oncol. 2021 May 13;11:646971. doi: 10.3389/fonc.2021.646971. eCollection 2021. Front Oncol. 2021. PMID: 34055615 Free PMC article.
14 results